52 North

Entia

This company develops at-home blood monitoring devices for cancer patients to share results with healthcare providers and improve treatment management.

LEUKO

This company develops a non-invasive device for monitoring white blood cell levels at home for cancer patients undergoing chemotherapy.

SepsiScan

This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.

Luminate Medical

This company develops wearable medical devices to prevent chemotherapy side effects and facilitate at-home cancer treatment for oncology patients and healthcare providers.

Novus Diagnostic

Novus Diagnostics develops point-of-care diagnostic devices for clinicians to detect and classify bloodstream infections, specifically sepsis, within fifteen minutes at the bedside.

Advanced Perfusion Diagnostics

This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.

Septest

This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.

Enzyre

This company develops a portable diagnostic device for haemophilia patients to monitor blood coagulation status and manage treatment from home.